Prophylactic antifungal therapy in the intensive care unit.
about
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unitAntifungal agents for preventing fungal infections in non-neutropenic critically ill patientsEpidemiology of invasive candidiasis: a persistent public health problemWeekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Canadian clinical practice guidelines for invasive candidiasis in adults.The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.Therapeutic dilemma of fluconazole prophylaxis in intensive care.Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.Invasive fungal disease in PICU: epidemiology and risk factors.Bench-to-bedside review: Candida infections in the intensive care unit.Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial.Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.An Italian consensus for invasive candidiasis management (ITALIC).Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation.Invasive fungal infections in pediatric heart transplant recipients: incidence, risk factors, and outcomes.A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.Update on antifungal treatment of invasive Candida and Aspergillus infections.Candida Species Biofilms' Antifungal Resistance.The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.Candidemia in a Brazilian hospital: the importance of Candida parapsilosis.Candidemia em hospital terciário do nordeste do Brasil
P2860
Q21194915-2B45B1D2-2319-4135-B692-3A5081678F67Q24244555-C76DFB73-D716-49AA-884A-93AAD95E81E1Q29616758-59E035FD-CB43-447F-A2C6-9A9A3232DFD2Q33712955-305CA254-2259-4BEF-90A1-293734241D18Q34237335-4DC7BEF5-AA69-489D-B29A-54DA600F60FEQ34480715-8534C7AD-5F89-4DE7-A137-70DE680C9829Q34509391-4918857F-A7F5-45FE-9D95-004E75ABCA61Q34768471-BF3B93C7-2535-4DC7-BB75-213DF571BA99Q35835858-DD22C772-7EB3-4C84-8E5F-FB3115944936Q36641985-03677964-C9F4-4202-B1EC-3E1179750FEEQ36925821-79E3F18A-910E-41D1-A8F3-34F34F250C65Q37122502-E5FF0542-09D7-48C8-93A0-9CB8F544B0C3Q37344532-69000E49-23F5-407A-A87F-E88EEEEEC19DQ38165883-0B52F9BE-7D11-4FA4-8003-CE8F83E0BF69Q40064399-D146CBAE-B1DA-4F13-B5CC-36FA8EA64550Q44007394-902E8262-9ED6-424E-BDAC-155B7B17FFD7Q44564495-12607B37-912C-4018-8470-C3654876FD2DQ45017863-9BBC9759-D63E-4EB6-B3F5-57D009DC59B5Q48163282-6196EFBE-0BCF-417E-9AA4-F3021E201E95Q51188122-72795E3F-939D-4D4D-8A0D-189618CF1843Q51814641-B20DADAD-CB07-4B62-BDC7-A68FC2B28A93Q56970509-3308E743-BDD9-49A7-80DB-99FF5CB134E4
P2860
Prophylactic antifungal therapy in the intensive care unit.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prophylactic antifungal therapy in the intensive care unit.
@ast
Prophylactic antifungal therapy in the intensive care unit.
@en
Prophylactic antifungal therapy in the intensive care unit.
@nl
type
label
Prophylactic antifungal therapy in the intensive care unit.
@ast
Prophylactic antifungal therapy in the intensive care unit.
@en
Prophylactic antifungal therapy in the intensive care unit.
@nl
prefLabel
Prophylactic antifungal therapy in the intensive care unit.
@ast
Prophylactic antifungal therapy in the intensive care unit.
@en
Prophylactic antifungal therapy in the intensive care unit.
@nl
P2860
P356
P1476
Prophylactic antifungal therapy in the intensive care unit.
@en
P2860
P304
P356
10.1086/319763
P407
P577
2001-03-26T00:00:00Z